piracetam has been researched along with Hemostatic Disorders in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Hemostatic Disorders: Pathological processes involving the integrity of blood circulation. Hemostasis depends on the integrity of BLOOD VESSELS, blood fluidity, and BLOOD COAGULATION. Majority of the hemostatic disorders are caused by disruption of the normal interaction between the VASCULAR ENDOTHELIUM, the plasma proteins (including BLOOD COAGULATION FACTORS), and PLATELETS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boon, P | 1 |
| Hulhoven, R | 1 |
| Offner, F | 1 |
1 trial available for piracetam and Hemostatic Disorders
| Article | Year |
|---|---|
Levetiracetam and bleeding disorders.
Topics: Adult; Anticonvulsants; Aspirin; Bleeding Time; Blood Coagulation; Cross-Over Studies; Double-Blind | 2007 |